Preclinical findings indicate that ABX-IL-8 can inhibit tumor growth in xenograft animals by interrupting the IL-8 signaling pathway, implying a wider therapeutic potential in mitigating SASP-driven inflammation in aged tissues [110]. The gene discussed is CXCL8; the disease is neoplasm.